ARIEL3 Was a Phase 3 Trial Looking at Rucaparib Significant improvement in progression-free survival - 102191

Spotlight
Video

ARIEL3 Was a Phase 3 Trial Looking at Rucaparib Significant improvement in progression-free survival

Cancer-News has 184 videos Subscribe Here

Loading........
Description: Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, discusses how ARIEL3 Was a Phase 3 Trial Looking at Rucaparib Significant improvement in progression-free survival.
Shared By : Cancer-News
Posted on : 04/10/18
Added : 1 year ago
Category : Ovarian Cancer



Recommended

Nothing found.